Who owns Elevation Oncology Inc?
- Ticker: ELEV
- CUSIP Number: 28623u101
Tip: Access positions for across all investors
Analyze quarterly positions in Elevation Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Elevation Oncology stock
Who bought or sold Elevation Oncology Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 17k | $6.1k | 100% | Jun 2025 |
|
| FNY Investment Advisers | 10k | $3.0k | 100% | Jun 2025 |
|
| Advisor Group Holdings | 2.0k | $720.000000 | 0% | Sep 2025 |
|
Who sold out of Elevation Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Frazier Life Sciences Management | Jun 2025 | 6.0M | $2.2M |
| BML Capital Management | Jun 2025 | 5.9M | $2.2M |
| Aisling Capital Management | Jun 2025 | 2.8M | $1.0M |
| Vanguard Group | Jun 2025 | 2.3M | $828k |
| Opaleye Management | Jun 2025 | 1.4M | $529k |
| Deltec Asset Management | Jun 2025 | 1.4M | $527k |
| Millennium Management | Jun 2025 | 1.4M | $523k |
| Susquehanna International | Jun 2025 | 1.0M | $371k |
| Rangeley Capital | Jun 2025 | 905k | $332k |
| ExodusPoint Capital Management | Jun 2025 | 597k | $219k |
| Geode Capital Management | Jun 2025 | 539k | $198k |
| Citadel Advisors | Jun 2025 | 405k | $149k |
| BlackRock | Jun 2025 | 369k | $136k |
| Sphera Funds Management | Jun 2025 | 329k | $121k |
| Gts Securities | Jun 2025 | 300k | $110k |
| Palumbo Wealth Management | Jun 2025 | 295k | $108k |
| Ameriprise Financial | Jun 2025 | 294k | $108k |
| Yakira Capital Management | Jun 2025 | 263k | $97k |
| Jane Street | Jun 2025 | 255k | $94k |
| Two Sigma Investments | Jun 2025 | 254k | $93k |
| UBS Group | Jun 2025 | 202k | $74k |
| PenderFund Capital Management | Jun 2025 | 196k | $72k |
| State Street Corporation | Jun 2025 | 195k | $72k |
| Renaissance Technologies | Jun 2025 | 166k | $61k |
| Marshall Wace | Jun 2025 | 155k | $57k |
| Exome Asset Management | Jun 2025 | 110k | $41k |
| Two Sigma Advisers | Jun 2025 | 107k | $39k |
| Northern Trust | Jun 2025 | 91k | $33k |
| Goldman Sachs Group | Mar 2025 | 77k | $20k |
| Verition Fund Management | Jun 2025 | 77k | $28k |
| Qube Research & Technologies | Jun 2025 | 67k | $25k |
| Jpmorgan Chase & Co | Mar 2025 | 66k | $17k |
| AQR Capital Management | Jun 2025 | 52k | $19k |
| Virtu Financial | Jun 2025 | 50k | $18k |
| FMR | Jun 2025 | 49k | $18k |
| National Bank Of Canada /fi/ | Jun 2025 | 40k | $15k |
| Hrt Financial | Jun 2025 | 38k | $14k |
| Abel Hall | Jun 2025 | 33k | $12k |
| CSS | Jun 2025 | 30k | $11k |
| Nuveen | Jun 2025 | 24k | $8.8k |
| Simplex Trading | Jun 2025 | 23k | $8.0k |
| Tower Research Capital | Jun 2025 | 18k | $6.5k |
| Y-Intercept | Jun 2025 | 14k | $5.1k |
| Two Sigma Securities | Jun 2025 | 13k | $4.7k |
| Cibc World Markets | Mar 2025 | 13k | $3.2k |
| Balyasny Asset Management | Jun 2025 | 12k | $4.5k |
| Bnp Paribas Arbitrage, Snc | Jun 2025 | 5.1k | $1.9k |
| CWM | Jun 2025 | 5.0k | $2.0k |